Margin operasi: Qiagen (QGEN)

Simbol lan logo merek qiagen.com (QGEN)

Is it worth investing in Qiagen N.V. (QGEN), given its flawless image as a global leader in molecular diagnostics? Stability is confirmed by the moderate influence of contractors, as chemistry is produced in-house. An analysis of operating profitability via EBIT reveals a margin of safety, where the parameter has stabilized at 25.20. The business's resilience is guaranteed by a "razor-blade" model that locks customers into proprietary consumables.

qiagen.com (QGEN): Rentabilitas dodolan miturut bathi operasi saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Qiagen N.V. (QGEN)

- rega saham lan konsensus proyeksi valuasi:
- indikator kapitalisasi bursa perusahaan:
Analisis dhasar perusahaan:QGEN, Qiagen NV
Barang utama Qiagen Corp

To objectively assess the efficiency of Qiagen N.V. (QGEN), it is critical for a manager to understand the operating profit margin before interest and taxes. An EBIT margin analysis reveals the business's ability to generate cash flow from core operations, which for Qiagen N.V. is driven by the high margins of exclusive consumables for its installed base of analyzers.

Pesaing Qiagen N.V. (QGEN)

Margin dodolan operasi TEM|Margin dodolan operasi Ionis Pharma (IONS)|Rentabilitas operasi Repligen Corp (RGEN)|RNA - Rentabilitas dodolan operasi|crisprtx.com - Margin dodolan operasi|Tingkat bathi operasi WGS|RARE - Rentabilitas operasi|Beam Tx (BEAM) - Margin dodolan operasi|SRPT (Sarepta Therapeutics Inc) - Margin dodolan operasi|TWST: Rasio bathi operasi|TXG (10xgenomics.com) - Margin operasi|NTLA (Intellia Therapeutics, Inc.) - Rasio bathi operasi|Rentabilitas operasi Stoke Corp (STOK)|Rentabilitas kegiatan operasi BioLife|Margin operasi WVE (Wave Life Sciences Ltd)|MAZE: Rentabilitas dodolan miturut bathi operasi|Sionna Therapeutics, Inc. - Margin operasi|Tingkat bathi operasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Margin dodolan operasi|QURE - Rentabilitas kegiatan operasi|MGTX (MeiraGTx Corp) - Margin operasi|Rentabilitas dodolan operasi REGENXBIO Inc. RGNX|Rentabilitas operasi Solid Biosciences (SLDB)|Ocugen Corp - Rentabilitas dodolan miturut bathi operasi|Rentabilitas operasi Pacific Biosciences PACB|Rasio bathi operasi BNTC (Benitec)|Design Corp - Margin operasi|Rocket Pharmaceuticals - Rasio bathi operasi|Rentabilitas dodolan miturut bathi operasi 4D Molecular Therapeutics, Inc.|Rentabilitas dodolan operasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Margin operasi|Rentabilitas dodolan operasi Editas EDIT|Margin operasi SLN|ProQR Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi CDXS (Codexis, Inc.)|SGMO: Rentabilitas dodolan miturut bathi operasi|Nautilus Biotechnology - Margin operasi|Tingkat bathi operasi MGX (Metagenomi, Inc)|DTIL: Margin operasi|GBIO: Rasio bathi operasi|Rentabilitas operasi Boundless Bio Inc.|Margin dodolan operasi Exicure (XCUR)|Margin operasi IMNN|PHIO (Phio Pharmaceuticals Corp.) - Tingkat bathi operasi|Mustang Bio, Inc. - Margin dodolan operasi|RNAZ - Margin dodolan operasi|BNGO: Margin dodolan operasi|APDN (Applied DNA Sciences Inc) - Rentabilitas dodolan miturut bathi operasi|BLUE (Bluebird Bio) - Margin dodolan operasi|ImmunoPrecise Antibodies Ltd - Tingkat bathi operasi|OMGA (Omega Therapeutics Inc) - Margin operasi|Rentabilitas operasi OMIC|Rentabilitas operasi Regulus Therapeutics Inc. (RGLS)|Margin dodolan operasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Margin dodolan operasi|Tingkat bathi operasi TCON|UBX - Rentabilitas operasi